HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Bailly Selected Research

Proteins (Proteins, Gene)

1/2021Mechanism of action of glycyrrhizin against Plasmodium falciparum.
1/2021The subgroup of 2'-hydroxy-flavonoids: Molecular diversity, mechanism of action, and anticancer properties.
1/2020Flurbiprofen as a biphenyl scaffold for the design of small molecules binding to PD-L1 protein dimer.
1/2020Erinacine A and related cyathane diterpenoids: Molecular diversity and mechanisms underlying their neuroprotection and anticancer activities.
1/2019Pharmacological effectors of GRP78 chaperone in cancers.
4/2012Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II.
4/2011Tetraspanin CD151 as a target for antibody-based cancer immunotherapy.
12/2009Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D.
6/2009Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase.
8/2008Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Bailly Research Topics

Disease

86Neoplasms (Cancer)
10/2022 - 04/2002
19Leukemia
04/2012 - 04/2002
9Poisoning
10/2014 - 02/2002
6Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2003
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2019
5Colonic Neoplasms (Colon Cancer)
12/2019 - 01/2003
5Melanoma (Melanoma, Malignant)
04/2012 - 04/2002
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2022 - 12/2019
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2020 - 09/2007
4Carcinoma (Carcinomatosis)
10/2019 - 01/2004
3COVID-19
06/2022 - 10/2020
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 07/2009
3Breast Neoplasms (Breast Cancer)
01/2021 - 09/2004
3Leukemia P388
04/2012 - 05/2004
3Leukemia L1210
12/2008 - 08/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 01/2021
2Periodontitis
01/2022 - 11/2020
2Malaria
04/2021 - 01/2021
2Stroke (Strokes)
01/2021 - 01/2020
2Infections
01/2021 - 10/2020
2Inflammation (Inflammations)
10/2020 - 10/2019
2Cardiotoxicity
12/2019 - 09/2004
2Dysbiosis
11/2019 - 10/2019
2Lung Neoplasms (Lung Cancer)
07/2015 - 06/2009
2Neuroblastoma
10/2014 - 06/2009
2Experimental Melanoma
08/2002 - 04/2002
1Virus Diseases (Viral Diseases)
09/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2022
1Neoplasm Metastasis (Metastasis)
06/2022
1Carcinogenesis
06/2022
1Bacterial Infections (Bacterial Infection)
01/2022
1Cancer Pain
01/2022
1Aphthous Stomatitis (Aphthous Ulcer)
01/2022
1Obesity
01/2022
1Bone Resorption
01/2022

Drug/Important Bio-Agent (IBA)

36Pharmaceutical PreparationsIBA
06/2022 - 02/2002
26DNA (Deoxyribonucleic Acid)IBA
03/2020 - 07/2002
14Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
13Type I DNA Topoisomerases (Topoisomerase I)IBA
02/2015 - 11/2002
12AlkaloidsIBA
03/2011 - 07/2002
10Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2016 - 04/2003
8Monoclonal AntibodiesIBA
06/2021 - 12/2009
8Biological ProductsIBA
12/2020 - 08/2003
8PolyaminesIBA
01/2016 - 12/2008
7LigandsIBA
10/2022 - 06/2003
7Etoposide (VP 16)FDA LinkGeneric
01/2021 - 02/2006
7F14512IBA
01/2016 - 12/2008
6Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 04/2002
6CamptothecinIBA
10/2019 - 11/2002
6lamellarin DIBA
02/2015 - 04/2004
6SpermineIBA
10/2014 - 12/2008
6PoisonsIBA
12/2011 - 04/2004
5EnzymesIBA
09/2022 - 02/2002
5Doxorubicin (Adriamycin)FDA LinkGeneric
03/2020 - 04/2004
5S 23906-1IBA
01/2005 - 04/2002
4EdaravoneIBA
05/2022 - 12/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
04/2020 - 11/2005
4Phosphotransferases (Kinase)IBA
03/2020 - 09/2004
4Irinotecan (Camptosar)FDA LinkGeneric
03/2020 - 01/2003
4Cytotoxins (Cytolysins)IBA
10/2019 - 01/2003
4Podophyllotoxin (Condylox)FDA LinkGeneric
04/2012 - 02/2006
4lipoarabinomannan (LAM)IBA
07/2010 - 11/2003
3Antimalarials (Antimalarial Agents)IBA
04/2021 - 12/2003
3Cisplatin (Platino)FDA LinkGeneric
03/2020 - 01/2016
3Proteasome Endopeptidase Complex (Proteasome)IBA
08/2008 - 09/2004
3furamidine (DB75)IBA
02/2004 - 05/2002
2AntioxidantsIBA
05/2022 - 12/2019
2Transcription Factors (Transcription Factor)IBA
01/2022 - 07/2020
2Chalcone (Benzalacetophenone)IBA
01/2022 - 12/2020
2AntibodiesIBA
12/2021 - 03/2020
2RNA Precursors (Precursor, mRNA)IBA
08/2021 - 01/2004
2HMGB1 Protein (HMG1)IBA
01/2021 - 10/2020
2Plant ExtractsIBA
11/2020 - 10/2019
2Glycyrrhizic Acid (Glycyrrhizin)IBA
10/2020 - 10/2020
2Chemokine ReceptorsIBA
07/2020 - 01/2016
2Aldehyde DehydrogenaseIBA
03/2020 - 01/2019
2Docetaxel (Taxotere)FDA Link
03/2020 - 03/2011
2Carboplatin (JM8)FDA LinkGeneric
03/2020 - 01/2016
2Nucleic AcidsIBA
03/2020 - 07/2002
2Carbon Nanotubes (Carbon Nanotube)IBA
01/2016 - 10/2013
2Topoisomerase II InhibitorsIBA
10/2014 - 07/2012
2Fluorescent Dyes (Fluorescent Probes)IBA
02/2011 - 09/2004
2trioctyl phosphine oxide (TOPO)IBA
01/2011 - 03/2005
2UbiquitinIBA
08/2008 - 02/2007
2sampangineIBA
11/2005 - 12/2003
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
04/2005 - 02/2002
2Acronine (Acronycine)IBA
03/2004 - 04/2002
1CeroidIBA
11/2022
1Glycogen Synthase (Synthase I)IBA
09/2022
1rac1 GTP-Binding ProteinIBA
06/2022
1pyrazoloneIBA
06/2022
1Thiostrepton (Gargon)IBA
01/2022
1panduratin AIBA
01/2022
1InterleukinsIBA
01/2022
1amlexanox (Aphthasol)FDA Link
01/2022

Therapy/Procedure

10Drug Therapy (Chemotherapy)
11/2021 - 11/2002
9Therapeutics
06/2022 - 03/2004
3Immunotherapy
01/2022 - 04/2011
2Traditional Medicine (Folk Remedies)
01/2021 - 05/2004
2Aftercare (After-Treatment)
12/2019 - 12/2003